Approval · Notice of Compliance 38272 · 2026
ACULAR: Notice of Compliance 38272
Issued September 11, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38272
- Date
- September 11, 2026
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph reformatted to the Master Template. Removal of strength: 0.4% w/v
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACULAR | Not yet assigned | — |
Medicinal ingredients
- KETOROLAC TROMETHAMINE 0.5 PER